All Updates

All Updates

icon
Filter
Partnerships
Twist Bioscience partners with Aster Insights to launch AsterExome panel
Precision Medicine
Apr 27, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Precision Medicine

Precision Medicine

Apr 27, 2023

Twist Bioscience partners with Aster Insights to launch AsterExome panel

Partnerships

  • California-based genomics company Twist Bioscience Corporation has partnered with bioinformatics company Aster Insights to launch the AsterExome panel, a genetic analysis tool for cancer research.

  • The AsterExome panel has been integrated into Aster Insights' AVATAR program and enables whole exome sequencing with additional coverage of 620 cancer-associated genes. The panel uses data from the Total Cancer Care protocol, with more than 360,000 patients consenting to lifetime participation through the Oncology Research Information Exchange Network.

  • Twist Bioscience is a synthetic biology and genomics company whose proprietary technology involves "writing" DNA on a silicon chip, enabling faster and more cost-effective production of high-quality synthetic DNA. The company's product portfolio encompasses a wide range of synthetic DNA-based offerings, which include synthetic genes, tools specifically designed for next-generation sequencing (NGS) preparation, and antibody libraries that facilitate drug discovery and development. Twist is also exploring long-term opportunities in digital data storage using DNA and biologics drug discovery.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.